|
1
|
Alzheimer's Association: 2017 Alzheimer's
disease facts and figures. Alzheimer's Dementia. 13:325–373. 2017.
View Article : Google Scholar
|
|
2
|
Mushtaq G, Khan JA, Kumosani TA and Kamal
MA: Alzheimer's disease and type 2 diabetes via chronic
inflammatory mechanisms. Saudi J Biol Sci. 22:4–13. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Prince M, Bryce R, Albanese E, Wimo A,
Ribeiro W and Ferri CP: The global prevalence of dementia: A
systematic review and meta analysis. Alzheimers Dement. 9:63–75.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rawlings AM, Sharrett AR, Schneider AL,
Coresh J, Albert M, Couper D, Griswold M, Gottesman RF, Wagenknecht
LE, Windham BG and Selvin E: Diabetes in midlife and cognitive
change over 20 years: A cohort study. Ann Intern Med. 161:785–793.
2014. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ohara T, Doi Y, Ninomiya T, Hirakawa Y,
Hata J, Iwaki T, Kanba S and Kiyohara Y: Glucose tolerance status
and risk of dementia in the community: The hisayama study.
Neurology. 77:1126–1134. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kandimalla R, Thirumala V and Reddy PH: Is
Alzheimer's disease a type 3 diabetes? A critical appraisal.
Biochim Biophys Acta Mol Basis Dis. 1863:1078–1089. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
de la Monte SM and Wands JR: Alzheimer's
disease is type 3 diabetes-evidence reviewed. J Diabetes Sci
Technol. 2:1101–1113. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Steen E, Terry BM, Rivera EJ, Cannon JL,
Neely TR, Tavares R, Xu XJ, Wands JR and de la Monte SM: Impaired
insulin and insulin-like growth factor expression and signaling
mechanisms in Alzheimer's disease-is this type 3 diabetes? J
Alzheimers Dis. 7:63–80. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rivera EJ, Goldin A, Fulmer N, Tavares R,
Wands JR and de la Monte SM: Insulin and insulin-like growth factor
expression and function deteriorate with progressionof Alzheimer's
disease: Link to brain reductions in acet ylcholine. J Alzheimers
Dis. 8:247–268. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Goh SY and Cooper ME: Clinical review: The
role of advanced glycation end products in progression and
complications of diabetes. J Clin Endocrinol Metab. 93:1143–1152.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tanaka K, Yamaguchi T, Kanazawa I and
Sugimoto T: Effects of high glucose and advanced glycation end
products on the expressions of sclerostin and RANKL as well as
apoptosis in osteocyte-like MLO-Y4-A2 cells. Biochem Biophys Res
Commun. 461:193–199. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chang CC, Chen CY, Chang GD, Chen TH, Chen
WL, Wen HC, Huang C and Chang CH: Hyperglycemia and advanced
glycation end products (AGEs) suppress the differentiation of
3T3-L1 preadipocytes. Oncotarget. 8:55039–55050. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lin JA, Wu CH, Lu CC, Hsia SM and Yen GC:
Glycative stress from advanced glycation end products (AGEs) and
dicarbonyls: An emerging biological factor in cancer onset and
progression. Mol Nutr Food Res. 60:1850–1864. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sato T, Shimogaito N, Wu X, Kikuchi S,
Yamagishi S and Takeuchi M: Toxic advanced glycation end products
(TAGE) theory in Alzheimer's disease. Am J A1zheimers Dis Other
Demen 2l. 197–208. 2006. View Article : Google Scholar
|
|
15
|
Vitek MP, Bhattacharya K, Glendening JM,
Stopa E, Vlassara H, Bucala R, Manogue K and Cerami A: Advanced
glycation end products contribute to amyloidosis in alzheimer
disease. Proc Natl Acad Sci USA. 91:4766–4770. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lue H, Kleemann R, Calandra T, Roger T and
Bernhagen J: Macrophage migration inhibitory factor (MIF):
Mechanisms of action and role in disease. Microbes Infection.
4:449–460. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Grieb G, Merk M, Bernhagen J and Bucala R:
Macrophage migration inhibitory factor(MIF): A promising biomarker.
Drug News Perspect. 23:257–264. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Abed Y, Dabideen D, Aljabari B, Valster A,
Messmer D, Ochani M, Tanovic M, Ochani K, Bacher M, Nicoletti F, et
al: ISO-1 binding to the tautomerase activesite of MIF inhibits its
pro-inflammatory activity and increases survival in severe sepsis.
J Biol Chem. 280:36541–36544. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vujicic M, Senerovic L, Nikolic I, Saksida
T, Stosic-Grujicic S and Stojanovic I: The critical role of
macrophage migration inhibitory factor in insulin activity.
Cytokine. 69:39–46. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bacher M, Deuster O, Aljabari B,
Egensperger R, Neff F, Jessen F, Popp J, Noelker C, Reese JP,
Al-Abed Y and Dode R: The role of macrophage migration inhibitory
factor in Alzheimer's disease. Mol Med. 16:116–121. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Oyama R, Yamamoto H and Titani K:
Glutamine synthetase, hemoglobin alpha-chain, and macrophage
migration inhibitory factor binding to amyloid beta-protein: Their
identification in rat brain by a novel affinity chromatography and
in Alzheimer's disease brain by immunoprecipitation. Biochim
Biophys Acta. 1479:91–102. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li SQ, Yu Y, Han JZ, Wang D, Liu J, Qian
F, Fan GH, Bucala R and Ye RD: Deficiency of macrophage migration
inhibitory factor attenuates tau hyperphosphorylation in mouse
models of Alzheimer's disease. J Neuroinflammation. 12:1–11. 2015.
View Article : Google Scholar
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Luo XD, Xu B, Zhou J and Tian GP:
Protective effect of secretory factors of bone marrow mesenchymal
stem cells on beta-amyloid 1–40 induced apoptosis in PC12 cells. J
Clin Rehabilitat Tissue Eng Res. 13:7937–7941. 2009.
|
|
25
|
Kanehisa M, Furumichi M, Tanabe M, Sato Y
and Morishima K: KEGG: New perspectives on genomes, pathways,
diseases and drugs. Nucleic Acids Res. 45:D353–D361. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Benigni F, Atsunmi T, Calandra T, Metz C,
Echtenacher B, Peng T and Bucala R: The proinflammatory mediator
macrophage migration inhibitory factor induces glucose cataboilsm
in muscle. J Clin Invest. 106:1291–1300. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Blennow K, de Leon MJ and Zetterberg H:
Alzheimer's disease. Lancet. 368:387–403. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nagae T, Araki K, Shimoda Y, Sue LI, Beach
TG and Konishi Y: Cytokines and cytokine receptors involved in the
pathogenesis of Alzheimer's disease. J Clin Cell Immunol.
7:4412016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Heneka MT, Carson MJ, EI Khoury J,
Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T,
Vitorica J, Ransohoff RM, et al: Neuroinflammation in Alzheimer's
disease. Lancet Neurol. 14:388–405. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Azizi G and Mirshafiey A: The potential
role of proinflammatory and antiinflammatory cytokines in Alzheimer
disease pathogenesis. Immunopharmacol Immunotoxicol. 34:881–895.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Azizi G, Navabi SS, Al-Shukaili A,
Seyedzadeh MH, Yazdani R and Mirshafiey A: The role of inflammatory
mediators in the pathogenesis of Alzheimer's disease. Sultan Qaboos
Univ Med J. 15:e305–e316. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Azizi G, Khannazer N and Mirshafiey A: The
potential role of chemokines in Alzheimer's disease pathogenesis.
Am J Alzheimers Dis Other Demen. 29:415–425. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang Y, Gu R, Jia J, Hou T, Zheng LT and
Zhen X: Inhibition of macrophage migration inhibitory factor (MIF)
tautomerase activity suppresses microglia-mediated inflammatory
responses. Clin Exp Pharmacol Physiol. 43:1134–1144. 2016.
View Article : Google Scholar : PubMed/NCBI
|
